BCL2 and plasma cell myeloma: Considering the naturally hypoxic nature of the BM microenvironment, this discovery holds critical therapeutic implications.10 Data from the GEO database revealed that the expression of BCL2 is elevated in myeloma cells exposed to hypoxia compared to normoxia, suggesting a potential mechanism for increased survival of these cells in such conditions.